Erik Wilms

Head of Laboratory

University Name

Netherlands

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

60%

Pharmacology

40%

Pharmacokinetic

50%

Drug Utilization

30%

Cystic Fibrosis Research

20%

Pharmacoepidemiology

20%

Antibiotic Therapy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

“Incidence and predictors of rapid response to Remdesivir in COVID-19 patients: a retrospective cohort study”

Open Date: 2020-07-01

Close Date: 2022-12-01

Articles11

Particulate contamination in parenteral fluid from glass ampoules: compliance assessment and comparative analysis of needle types and ampoule-breaking strategies

Article Link

Year:

2025

Population Pharmacokinetics of Trimethoprim/Sulfamethoxazole: Dosage Optimization for Patients with Renal Insufficiency or Receiving Continuous Renal Replacement Therapy

Article Link

Year:

2024

Examination of Particulate Contamination in Parenteral Injections and Infusions Following Fluid Withdrawal Utilizing Conventional Needles and Filter Needles: Assessment of Compliance and Comparative Analysis

Article Link

Year:

2024

Evaluation of the drug–drug interaction between triazole antifungals and cystic fibrosis transmembrane conductance regulator modulators in a real-life cohort

Article Link

Year:

2024

Elexacaftor/tezacaftor/ivacaftor in liver or kidney transplanted people with cystic fibrosis using tacrolimus, a drug-drug interaction study.

Article Link

Year:

2024

Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study.

Article Link

Year:

2023

Drug–drug interaction: decreased posaconazole trough concentrations during concomitant flucloxacillin treatment

Article Link

Year:

2023

The influence of exocrine pancreatic function on the exposure and pharmacokinetics of ivacaftor in people with cystic fibrosis

Article Link

Year:

2023

Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients.

Article Link

Year:

2022

Real-life safety of PD-1 and PD-L1 inhibitors in older patients with cancer: An observational study.

Article Link

Year:

2022

Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the Prostate

Article Link

Year:

2022

Collaborators4

Cees van Nieuwkoop

Associate professor

Leiden University Medical Center

NETHERLANDS

Eleonora Swart

Head of Department

Amsterdam UMC Locatie AMC

NETHERLANDS

Brenda de Winter

Hospital Pharmacist - Assistant Professor

Erasmus University Medical Center

NETHERLANDS

Frederiek van den Bos

internist-geriatrician, associate professor

Leiden University Medical Center

NETHERLANDS

How do I reach out?

Meet Kite AI